The iWiMS July 15 2020 COVID-19 meeting hosted was hosted by Fabienne Brillot. We heard an update from Celine Louapre (French Registry), specifically talking about COVID-19 in people with NMOSD. Amber Salter (COViMS Registry US) gave an update on the US experience. Both speakers spoke to comorbidities, and treatment impacts.
The formal talks were followed by a discussion of DMT considerations given the data that has been presented and published over the last months. Together with a discussion of possible impact of steroid exposure on COVID outcomes. We again thank all of our speakers for their time and generosity in sharing their data with our community.
Please acknowledge the speakers if you use any of their data in your own presentations. Thank you. iWiMS team.
Please note, these videos are intended for a medical and scientific audience for educational purposes. All Registries collecting data on COVID-19 patients have been approved by research ethics committees/IRBs. Data are anonymised, no personal patient information is presented.